Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State. - Grivas P; Monk BJ; Petrylak D; Reck M; Foley G; Guenther S; Hennessy D; Makris C; Moehler M (Targeted oncology, 2019)